Actelion buys U.S.-based firm with cancer drug in development

[riky]

Actelion buys U.S.-based firm with cancer drug in development

<p><a href="http://news.yahoo.com/actelion-buys-u-based-firm-cancer-drug-development-155811086.html"><img src="http://l3.yimg.com/bt/api/res/1.2/1oJAS18emPRPqdW5ayrFgQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-07-31T155811Z_1_CBRE96U18D700_RTROPTP_2_SWITZERLAND.JPG" width="130" height="86" alt="A general view shows Swiss biotech group Actelion Headquarters in Allschwil" align="left" title="A general view shows Swiss biotech group Actelion Headquarters in Allschwil" border="0" /></a>ZURICH (Reuters) - Actelion said it will acquire Ceptaris, a privately held U.S.-based specialty pharmaceutical company developing a topical drug, Valchlor, to treat a form of cancer. Allschwil-based Actelion said it already paid Ceptaris $25 million and will pay another $225 million when the deal closes. The deal is contingent on Valchlor clinching approval from the U.S. health regulator. &quot;We expect the transaction to become cash-accretive before the end of 2014,&quot; Actelion executive Nicholas Franco said in a statement on Wednesday. (Reporting By Katharina Bart)</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login